Publications

Real-world evidence shows no survival advantage with contemporary first-line strategies in papillary renal cell carcinoma: A call for randomized trials

7.17.2025

Developing a digital twin framework for colorectal cancer outcome prediction and ...

(PB2488) Chart review study on the real-world cytopenia management of patients with ...

(PB2779) Chart review study on dose modifications of patients with myelodysplastic ...

Comparison of outcomes for patients (pts) with R/R chronic lymphocytic leukemia ...

Treatment patterns and survival by race among men with metastatic ...

Survival impact of adjuvant chemotherapy regimens for small (T1mi/a/b), ...

Leveraging real-world data sources for clinical oncology research: A review of ...

Analysis of ASCO clinical guidelines authorship and institutional representation ...

Real-world side effects of targeted therapies: High-throughput association studies ...

Epidemiology of MET gene mRNA expression in metastatic colorectal cancer: Analyses ...

Pediatric cancer in the United States: A comparison of three data sources

The value of integrating urology and oncology real-world data for understanding ...

Real-world use of accelerated approval oncology drugs subsequently withdrawn in the ...

Comparing traditional NLP methods and LLM-based extraction for identifying ...

Electronic health records (EHR)-based machine learning (ML) approach to predict risk ...

Machine learning model to forecast patient availability for oncology clinical trials

Real-world clinical outcomes of patients with metastatic colorectal cancer (mCRC) ...

Real-world patient characteristics and treatment patterns among cholangiocarcinoma ...

Folate receptor alpha (FRα; FOLR1) expression and persistence in ovarian cancer in ...

CO125: Adjusted comparison of amivantamab in combination with carboplatin plus ...

HSD64: Real-world adjuvant nivolumab utilization in surgically treated ...

P32: Oncology trial emulation using real-world electronic health record data: ...

RWD116: Training and validation of CARAai™: A multi LLM platform and data model to ...

EPH131: Estimating US cancer prevalence with community oncology EHR-based datasets ...

6638 / 19 - Identifying cancer germline variants associated with patient prognosis ...

3395 / 15 - Investigating clinical features and molecular mechanisms of long-term ...

Poster

Leveraging large language models to drive efficiency in clinical trial simulation

Real-world treatment patterns and survival in men with metastatic ...

Survival outcomes among metastatic castration-resistant prostate cancer patients ...

Clinical use and outcomes of androgen-receptor pathway inhibitors triplet therapy ...

Recurrence and its association with overall survival (OS) in muscle-invasive bladder ...

Real-world clinical outcomes of trifluridine-tipiracil monotherapy (FTD-TPI) and ...

Real-world clinical outcomes of patients (pts) with metastatic colorectal cancer ...

Biomarkers of response in patients with gastric/gastroesophageal junction ...

P1-09-09: Disparities in second breast cancer events and survival persist despite ...

P3-03-12: Social determinants of health (SDOH) and Z code utilization among patients ...

P1-08-09: Real-world outcomes comparing 3-monthly with monthly goserelin implant in ...

5189 Real-world use patterns and clinical outcomes for myelodysplastic syndrome ...

4437 Real-world treatment patterns in patients with mycosis fungoides or Sezary ...

4623 Mutations in the Bruton tyrosine kinase (BTK) gene in patients with chronic ...

656P Real-world (RW) frontline (1L) treatments (Txs) in patients (Pts) with advanced ...

Real-world treatment and clinical outcomes in patients with metastatic ...

RWD23 Addition of open administrative claims significantly improves capture of ...

Real-world clinical outcomes among patients with non-squamous advanced non-small ...

245P - Characteristics of real-world (RW) NATALEE and monarchE eligible populations: ...

1303P - METPRO: Evaluating prognostic value of c-Met protein overexpression and ...

1352P - Real-world second-line outcomes of NSCLC patients receiving first-line ...

EP.11A.08 Real-world comparative effectiveness in advanced NSCLC and high PD-L1 with ...

EP.12A.03 Overall survival after treatment with first-line osimertinib for ...

1361: Quantification of information gained by linking claims data to an EHR cohort ...

435: Identifying the period of heightened risk for adrenal insufficiency in patients ...

1433: Pediatric cancer in the United States: A comparison of two data sources

803: Representativeness of race, ethnicity and social determinants of health in ...

1231: Unlocking insights: Lesson learned from the tokenization of a psoriasis trial

242: A combined machine learning and natural language processing approach to ...

Poster

Assessing feasibility of using RWD to support biosimilar development: Rituximab use ...

Rapid and deep prostate-specific antigen (PSA) response to apalutamide plus ADT and ...

A real-world study on biomarker retesting among patients with non-small cell lung ...

Representativeness of race, ethnicity and social determinants of health in patients ...

Electronic clinical quality measure (eCQM) concordance and quality care disparities ...

Disparities in patients with HER2-positive breast cancer receiving optimal ...

Predicting real-world overall survival for post-operative pancreatic ductal ...

Pancreatic Cancer

Real-world baseline treatment patterns and overall survival (rwOS) in patients (pts) ...

Dynamic machine learning model to forecast patient availability for clinical trials

A prospective study comparing AI-based clinical trial eligibility screening with ...

Efficient site selection for clinical trials using simulated annealing

An emulation of the KEYNOTE-189 trial using electronic health records

Budget impact of pirtobrutinib for patients with mantle cell lymphoma (MCL) or ...

Comparative analysis of different methods of disease progression data capture in ...

Proportional randomization method to identify index line of therapy in externally ...

MP51-18 Population-based trends and outcomes for cytoreductive nephrectomy for ...

MP31-17 Variation in genomic testing amongst localized prostate cancer patients ...

Integrating real-world histopathological and clinicogenomic data from 1799 lung ...

Harness the power of real-world-data for oncology target and biomarker research: A ...

KRAS co-mutational landscape dictates treatment outcomes in pancreatic cancer (PC) ...

Pancreatic Cancer

Identifying the genetic basis for resistance to aromatase inhibitors (AIs) in ...

Predicting progression-free survival (PFS) in first-line (1L) immune checkpoint ...

Identifying co-mutational signatures in STK11 mutated advanced non-small cell lung ...

Patterns of concurrent chemotherapy selection in US patients undergoing trimodality ...

Real world evidence comparison of first-line (1L) immune-oncology(IO)/tyrosine ...

Survival outcomes of APA as a starting treatment: Impact in real-world patients with ...

Real-world homologous recombination repair mutation (HRRm) testing patterns in ...

Real-world treatment patterns, testing patterns, and clinical outcomes of first-line ...

Real-world progression-free survival and treatment patterns for t(11;14) positive ...

Real-world treatment patterns and healthcare resource utilization in patients with ...

269 Impact of ibrutinib dose reduction on duration of therapy in patients with ...

Augmentation of real-world mortality data in the electronic medical record: ...

3358 Real-world evaluation of outcomes in relapsed/refractory multiple myeloma ...

5100 Machine learning approach to understand real-world treatment in patients with ...

5143 Impact of real-world treatment sequencing patterns on time to next treatment ...

Abstract PO1-17-07: Invasive disease-free survival as a surrogate for overall ...

Disparities in genetic testing patterns and positivity among patients with breast ...

Picturing progression: A new role of whole slide imaging in comprehensive clinical ...

573P LUMINATE-103: Real-world treatment patterns and outcomes of patients (pts) with ...

PP01.46 Real-world rebiopsy and biomarker retesting rates among patients with ...

PP01.58 Real-world outcomes in patients with EGFR wildtype non-squamous locally ...

Risk of Death Before and After Metastasis in High-Risk Localized and Locally ...

A machine learning model to facilitate patient-level risk screening in ...

Augmenting synthetic control arms using Bayesian borrowing: a case study in ...

Post-metastasis survival in high-risk localised and locally advanced prostate cancer ...

Uptake and efficacy of immuno-oncology combinations in metastatic renal cell ...

Implementing a BRAF biomarker electronic clinical quality measure in CancerLinQ

Real-world treatment patterns and clinical outcomes post standard of care (SOC) ...

Real-world (RW) use patterns, effectiveness, and tolerability of sacituzumab ...

LUMINATE 102: A real-world study on biomarker testing rates among patients with ...

Abstract A131: Clinical characteristics and outcomes of Black patients with multiple ...

Supporting the use of RWD in oncology drug development, Session 1: Establishing a ...

Panel

Evaluation of treatment strategies for patients with stage IIIA non-small cell lung ...

MDS-567 Real-world analysis of a large electronic medical record database of ...

957 Machine learning (ML) model for prediction of pneumonitis using real-world data ...

Real-world management and outcomes for newly diagnosed AML patients initiating ...

Real-world analysis of a large electronic medical record database of patients with ...

P572: Real-world management and outcomes for newly diagnosed AML patients initiating ...

The RESECT study: Factors associated with overall survival (OS) and relapse-free ...

Pitfalls with analyses of real-world data: A look at ASCO’s CancerLinQ Discovery ...

Real-world outcomes with adjuvant nonsteroidal aromatase inhibitors (NSAIs) vs ...

Site of metastasis (SoM) and its impact on clinical outcomes in 8 cancer cohorts

Development of natural language processing (NLP) models for extracting key features ...

Enhancement in line of therapy (LoT) derivation from real-world data (RWD) from ...

Racial and ethnic representation in large B-cell lymphoma trials and real-world ...

Real-world clinical outcomes in patients (pts) with HR+/HER2- metastatic breast ...

Real-world outcomes in patients (pts) with metastatic triple-negative breast cancer ...

A real-world study of US patients with metastatic ovarian, fallopian tube, and ...

Association between severe adverse event management and overall survival in patients ...

Treatment patterns and outcomes among locally advanced cervical cancer patients ...

Real-world response endpoints in patients with mNSCLC treated with chemotherapy ...

Treatment outcomes in patients (pts) with advanced/metastatic non‑small cell lung ...

Biomarker testing and treatment patterns in US patients (pts) with ...

Evaluating clinical trial inclusion/exclusion criteria from claims using generative ...

Electronic health record (EHR) and genomics-based machine learning (ML) to predict ...

Assessment of electronic health record (EHR) –based machine learning (ML) in ...

Identification of biomarkers for early progression in muscle invasive bladder cancer ...

Digital trial solutions eScreening: software to rank patients by their predicted ...

Electronic health record (EHR)-based machine learning (ML) to predict disease ...

Real-world treatment (Tx) patterns in patients (pts) with HR+/HER2- metastatic ...

CO210 Real-World Effectiveness and Treatment Patterns of Venetoclax-Based Regimens ...

Real-world study on characteristics, post-nephrectomy journey, and outcomes of ...

Patient characteristics, treatment patterns, and factors of biomarker testing among ...

Association of clinical trial enrollment and mortality amongst patients with ...

Variation of hormonal agent usage with postoperative radiation therapy: Results from ...

Machine learning (ML) on real-world data (RWD) of front-line (1L) metastatic ...

Machine learning (ML) model for prediction of pneumonitis using real-world data ...

Genomic landscape of patients with non-small cell lung cancer (NSCLC)

Evaluation of patients with multiple EGFR genomic tests in the metastatic NSCLC ...

19P Mortality among EGFR-mutated advanced NSCLC patients after frontline osimertinib ...

Comparative effectiveness of abiraterone and enzalutamide in the first-line ...

Real-world treatment patterns and sequencing in patients with locally advanced or ...

Real-world treatment patterns and outcomes of daratumumab retreatment in multiple ...

Treatment patterns and outcomes in patients with relapsed/refractory multiple ...

STREAMLINE - Retrospective cohort study of FLT3-mutated acute myeloid leukemia ...

Early-stage unfavorable Hodgkin lymphoma: Patient characteristics in real-world ...

Racial disparities in newly diagnosed hematological malignancies in the United ...

Secondary primary malignancies (SPMs) in adolescent and young adults (AYAs) with ...

Survival of patients with multiple myeloma diagnosed with second primary ...

Real world treatment patterns of adjuvant endocrine therapy and ovarian suppression ...

Effect of COVID-19 vaccination status on adverse events and outcomes in advanced ...

Identifying genetic factors for resistance and response to immune checkpoint ...

Real-world outcomes among HER2-positive metastatic breast cancer patients treated ...

Real-world patient profiles, treatment patterns, and outcomes among recurrent, ...

Lurbinectedin vs an external control arm in patients with small cell lung cancer

Unmet need in heavily pre-treated patients with HR+/HER2- metastatic breast cancer ...

935P - Demographics, clinical characteristics, treatment patterns and clinical ...

Use of immunosuppressive drugs and the effectiveness of immune checkpoint inhibitor ...

Treatment patterns and outcomes among patients with EGFR-mutant advanced NSCLC in ...

Long term survival outcomes in NSCLC patients with targeted therapy and ...

Outcomes for patients with mantle cell lymphoma post-covalent BTK inhibitor therapy ...

Outcomes for patients with chronic lymphocytic leukemia previously treated with a ...

Efficacy of lurbinectedin in a clinical trial versus standard of care in a ...

Machine learning modeling of real-world primary resistance and hyperprogression in ...

Disparities in timely treatment among lung cancer patients

Real-world outcomes among patients with metastatic colorectal cancer treated first ...

Natural language processing-optimized case selection for real-world evidence studies

Disease-free and overall survival outcomes for localized RCC patients by disease ...

Identifying genetic factors of response and resistance to CDK4/6 inhibitors in ...

Impact of trial site selection on minority patient recruitment in prostate cancer ...

Evaluating the impact of performance status criteria on minority eligibility for ...

Comparison of DNA sequencing, immunohistochemistry, and in-situ hybridization ...

Clinical outcomes with alpelisib (ALP) plus fulvestrant (FUL) after prior treatment ...

Race differences in patient-reported symptoms and adherence to adjuvant endocrine ...

Associations between biomarker testing and characteristics of patients with ...

Molecular testing and patterns of treatment in NSCLC patients: An IASLC analysis of ...

The survival benefit of anti-HER2 treatment in the management of small (T1mic, T1a, ...

Diagnosed with advanced prostate cancer: A population-based cohort from national ...

Characterizing node-negative non-small cell lung cancer patients with similarity ...

Cohort optimizer, a software solution that uses real-world data and AI to optimize ...

Disease-free survival (DFS) as a predictor of overall survival in completely ...

Treatment patterns, overall survival (OS), and disease-free survival (DFS) in ...

Outcomes for patients with mantle cell lymphoma post-covalent BTK inhibitor therapy ...

Enhancing diversity in oncology clinical trials: Findings of a case study in ...

Treatment patterns and outcomes associated with sequential and non-sequential use of ...

Mild or moderate adverse events (AEs) and their management in patients receiving ...

Care at the end of life during the COVID-19 pandemic: A CancerLinQ Discovery® (CLQD) ...

Development of a breast cancer-specific prognostic tool using CancerLinQ Discovery

Survival in the real world: A national analysis of patients treated for early stage ...

Real-world treatment patterns among patients diagnosed with metastatic ...

The Friends of Cancer Research Real World Data (RWD) Pilot 2.0 Collaboration: ...

Assessment of differences in demographic characteristics and clinical diagnoses ...

Machine learning imputation of metastatic status from open claims in melanoma ...

Algorithm to derive progression based lines of therapy from a real world non-small ...

Real-world treatment patterns among patients diagnosed with metastatic ...

Differences by race in patient-reported symptoms during chemotherapy among women ...

Treatment patterns and characteristics in the second and third-line therapy setting ...

Overall survival throughout treatment course among patients diagnosed with small ...

Disruptions to US medical oncology care during the COVID-19 pandemic: CancerLinQ ...

Real-world progression-free survival by timing of molecular profiling testing among ...

773 - Evaluating clinical features and prognostic factors associated with response ...

Non-interventional cohort study on patients with advanced non-small cell lung cancer ...

66P - EGFR testing patterns and survival in stage I‒III non-small cell lung cancer ...

Demographic and clinical characteristics of advanced ovarian cancer patients treated ...

Demographics, clinical characteristics, and treatment patterns for patients with ...

Trends in biomarker testing among advanced NSCLC patients in oncology practice ...

Real-world effectiveness of EGFR TKI first-line treatment of advanced EGFR ...

Natural history and real-world treatment outcomes for NSCLC patients with EGFR exon ...

Demographics and clinical characteristics of metastatic colorectal cancer patients ...

Treatment patterns and outcomes of hepatocellular carcinoma (HCC) patients (pts) in ...

Locoregional recurrence in patients with early-stage triple-negative breast cancer ...

Real-world clinical outcomes of patients with BRCA-mutated (BRCAm) HER2-negative ...

Streamline – Retrospective cohort study of relapsed or refractory (R/R) FLT3 mutated ...

Real-world conditional survival analysis of patients with relapsed/refractory ...

Healthcare resource utilization and cost in patients with relapsed/refractory ...

Metastatic colorectal cancer patients treated with a biosimilar to bevacizumab in ...

Treatment patterns, healthcare resource utilization and cost among ...

Racial disparities in performance status among cancer patients at a community ...

The relationship between treatment intensity and characteristics of patients with ...

Impact of curated data on electronic quality measure capture rates within CancerLinQ

Disproportionate impact of COVID-19 disease among racial and ethnic minorities in ...

Tumor mutational burden (TMB) level and clinical outcomes in a real-world pan-tumor ...

Real-world evidence on use of tumor mutation burden in a pan-tumor population.

Demographics and clinical characteristics of metastatic colorectal cancer patients ...

Treatment patterns and effectiveness outcomes in patients with relapsed/refractory ...

Annual trends in opioid prescribing for patients with metastatic non-small cell lung ...

Identification of transgender people with cancer in electronic health records (EHR): ...

Machine learning imputation of Eastern Cooperative Oncology Group performance status ...

Artificial intelligence model to predict slow progression for advanced non-small ...

Predicting cardiac adverse events in patients receiving immune checkpoint ...

Trends in immunotherapy use in patients with advanced non-small cell lung cancer ...

Development of an artificial intelligence model to dynamically predict metastatic ...

Development of an algorithm using natural language processing to identify metastatic ...

Using an ePRO tool to help meet quality metric reporting standards: screening for ...

Performance of time to discontinuation and time to next treatment as proxy measures ...

Vital status ascertainment in cancerlinq discovery (CLQD): Improvement in mortality ...

Overall survival (OS) in advanced non-small cell lung cancer (aNSCLC) patients ...

Treatment trends with immune checkpoint inhibitor (ICI) therapy in older adults with ...

Low rates of BRCA1 and BRCA2 testing for patients with ovarian cancer in ASCO's ...

Cost and healthcare resource utilization (HCRU) for patients receiving neoadjuvant ...

Occurrence of brain metastasis and treatment patterns among patients with ...

Retrospective electronic health records study in the CancerLinQ Discovery database ...

Identifying non-small cell lung cancer patients from a cohort of heterogeneous lung ...

Performance of time to discontinuation and time to next treatment as proxy measures ...

Progression-free survival, overall survival, and tumor response for patients ...

Treatment patterns, healthcare resource utilization and patient-reported outcomes ...

Poster

Patient and provider characteristics associated with first-line treatment of ...

Breast Cancer

Retrospective electronic medical records study of treatment patterns among CLL ...

Capturing patient advance directives status in a community oncology practice using ...

Streamline - study of relapse or refractory (R/R) FLT3-mutated acute myeloid ...

Using an ePRO tool to help meet quality metrics in a community oncology practice

Real-world outcomes in patients receiving neoadjuvant chemotherapy for early-stage ...

Patient characteristics and real-world treatment patterns in patients with ...

Using artificial intelligence to improve capture of metastatic breast cancer (BC) ...

Real-world characteristics and outcomes of patients with advanced non-small cell ...

Characteristics of patients receiving immune checkpoint inhibitors (ICI) in ASCO’s ...

Real-world prevalence of autoimmune disease (AD) among patients (pts) receiving ...

Real-world outcomes of patients with advanced non-small cell lung cancer (aNSCLC) ...

Impact of broadening clinical trial eligibility criteria for advanced non-small cell ...

Development of an artificial intelligence model to predict survival at specific time ...

Outcomes among metastatic breast cancer patients with characteristics that confer a ...

Real-world treatment patterns and clinical outcomes with palbociclib combination ...

Assessing the real-world cost of care in patients with metastatic triple negative ...

Artificial intelligence methods to predict chemotherapy-induced neutropenia in ...

Understanding health-related quality of life (HRQoL) in unresected stage III ...

Poster

Time spent on rituximab infusion and its impact on patient and caregiver burden

Poster

Real-world effectiveness outcomes by race in patients with metastatic triple ...

Breast Cancer

Poster

Real-world treatment patterns and clinical outcomes stratified by age, in women with ...

Breast Cancer

Effect of pegfilgrastim on-body injector (OBI) on cancer care: A real-world health ...

Impacts of time spent on rituximab infusion on patient satisfaction, stress, ...

Patient reported outcomes in metastatic renal cell carcinoma patients receiving ...

Clinical outcomes among patients with unresected stage III non-small cell lung ...

Real-world treatment patterns among patients with unresected stage III non-small ...

Progression-free survival and overall survival in advanced squamous cell carcinoma ...

Patient-reported outcomes among those taking pazopanib for metastatic renal cell ...

Health resource utilization and costs in BRCA-positive metastatic breast cancer ...

Poster

Health care cost in patients with advanced non-small cell lung cancer and disease ...

Lung Cancer

Poster

Real-world clinical outcomes in BRCA-positive metastatic breast cancer patients ...

Breast Cancer

Poster

Progression-free survival in advanced head and neck cancer: retrospective analysis ...

Poster

Characteristics of patients treated with fulvestrant as first hormonal therapy for ...

Breast Cancer

Treatment patterns and outcomes in metastatic bladder cancer in community oncology ...

Poster

Patient characteristics and costs in advanced head and neck cancer: retrospective ...

Poster

Clinical and health economic burden of attempted primary cancer site identification ...

unknown primary

Effectiveness outcomes in patients with advanced NSCLC treated in real world ...

Impact of disease progression on patient reported outcomes in advanced NSCLC: ...

Effect of brain metastasis on patient reported outcomes in advanced NSCLC treated in ...

Poster

Treatment outcomes in patients with metastatic neuroendocrine tumors: retrospective ...

Treatment patterns and outcomes in patients with KRAS wild type metastatic ...

Oral Presentation

Maximizing the utility of real world evidence: integration of structured EMR data, ...

Poster

The impact of extended endocrine therapy on symptom burden and health-related ...

Breast Cancer

Poster

Treatment patterns and outcomes in metastatic neuroendocrine tumors: results from a ...

Poster

Real-world impact of treatment-induced peripheral neuropathy of patient-reported ...

Multiple Myeloma

Real-world impact of treatment-induced peripheral neuropathy of patient-reported ...

US burden of illness associated with adjuvant therapy for stage I-III melanoma

Real-world treatment patterns and health resource utilization among patients ...

Poster

Treatment patterns and baseline characteristics of a prospective cohort of patients ...

Lung Cancer

Association of treatment induced peripheral neuropathy with treatment patterns and ...

Clinical trial subjects compared to patients treated in "real world" practice: ...

Association of treatment induced peripheral neuropathy (TIPN) with treatment ...

Community oncology treatment patterns and clinical effectiveness in metastatic ...

Poster

Using text mining of electronic medical records to identify KRAS testing status in ...

Colorectal Cancer

Poster

Burden of symptoms associated with development of metastatic bone disease in ...

Breast Cancer

Poster

Use of a validated assessment tool demonstrates the frequency of ...

Real world symptom burden and early treatment discontinuation in 1st line metastatic ...

Predicting risk of chemotherapy-induced side effects in patients with colon cancer ...

KRAS testing of mCRC patients in a community-based oncology setting

Poster

Early treatment discontinuation and switching in 1st line metastatic breast cancer: ...

Breast Cancer

Poster

Adverse events among patient treated for metastatic renal cell carcinoma (mRCC): ...

Poster

Adverse events (AEs) by age: data from a real world, multicenter registry of ...

Poster

Treatment patterns and clinical characteristics of patients with advanced basal cell ...

Basal Cell Carcinoma

Poster

Treatment patterns and outcomes in metastatic gastric cancer in the community ...

Outcomes of “real world” treatment for metastatic renal cell carcinoma (mRCC)

Poster

Willingness to pay to prevent chemotherapy induced nausea and vomiting

Poster

Cancer patient preferences and willingness to pay for preventing chemotherapy ...

Poster

Treatment patterns among patients with metastatic melanoma treated in the community ...

Melanoma

Poster

“Real world” treatment of metastatic renal cell carcinoma (mRCC) in community and ...

Poster

Testing and treatment patterns in HER2+ breast cancer patients in the adjuvant ...

Breast Cancer

Poster

Symptom burden declines when breast cancer patients treated with adjuvant ...

Breast Cancer

Poster

Treatment patterns, medical resource use, and costs associated with second line ...

Lung Cancer

Poster

Engagement of lung cancer patients in quality of life assessments administered by ...

Lung Cancer

Symptom burden in patients with follicular lymphoma undergoing maintenance treatment ...

Oral Presentation

Considerations in the use of secondary data sources for oncology research

Poster

The effect of disease progression on patient reported outcomes in HER-2 negative ...

Breast Cancer

Poster

Psychosocial impact of cancer related symptoms among patients with lung cancer

Lung Cancer

Poster

Relation of sleep disturbance, depression, pain, and fatigue in patients with cancer

Poster

Irinotecan is associated with greater symptom burden than oxaliplatin in metastatic ...

Colorectal Cancer

Poster

Prevalence of insomnia and associated symptoms in patients with cancer

Poster

Practice patterns of community based adjuvant hormonal therapy (AHT) in early stage ...

Breast Cancer

Poster

Patient survey of the impact of toxicities with FOLFOX + Bevacizumab (BV) in 1st ...

Colorectal Cancer

STREAMLINE - Retrospective cohort study of FMS-like tyrosine kinase 3-mutated acute ...

Patients with advanced non-small cell lung cancer harboring MET alterations: A ...

Identification of predictive subphenotypes for clinical outcomes using real world ...

Biomarker testing and patterns of treatment in NSCLC patients: An IASLC analysis of ...

Practice patterns and outcomes of conventional versus split-dose cisplatin in ...

Post-metastasis survival of patients with high-risk localized and locally advanced ...

Prognostic score models for acquired resistance to frontline anti-programmed cell ...

Real-world frontline treatments in patients with advanced non-small-cell lung cancer ...

Goserelin 3-month depot shows non-inferiority to the monthly formulation in U.S. ...

Survival outcomes of apalutamide as a starting treatment: Impact in real-world ...

Behavior of test specificity under an imperfect gold standard: Findings from a ...

Real-world effectiveness of frontline treatments among patients with chronic ...

Management of severe immune-related adverse events and outcomes in patients with ...

Racial disparities in clinical trial enrollment among patients diagnosed with ...

Clinical characteristics and treatment of patients with small cell prostate cancer: ...

Evaluation of treatment strategies for patients with stage IIIA non-small cell lung ...

Real-world outcomes following ibrutinib dose reduction in patients with chronic ...

Calibrating observational health record data against a randomized trial

Emulations of oncology trials using real-world data: A systematic literature review

Real-world treatment patterns and outcomes in patients with HR+/HER2− metastatic ...

Treatment intensification in metastatic hormone-sensitive prostate cancer: An ...

Evaluation of real-world tumor response derived from electronic health record data ...

A retrospective analysis of treatment patterns, overall survival, and real-world ...

Seeking American Society of Clinical Oncology-QualityOncology Practice Initiative ...

Prognosis and conditional survival among women with newly diagnosed ovarian cancer

Real-world treatment patterns of adjuvant endocrine therapy and ovarian suppression ...

The survival benefit of adjuvant trastuzumab with or without chemotherapy in the ...

EGFR mutation testing, treatment and survival in stage I–III non-small-cell lung ...

Real-world use patterns, effectiveness, and tolerability of sacituzumab govitecan ...

Comparing prospectively assigned trial and real-world lung cancer patients

Real-world study on the characteristics, post-nephrectomy journey, and outcomes of ...

Improving cancer data interoperability: The promise of the minimal Common Oncology ...

Development of CancerLinQ, a health information learning platform from multiple ...

Summary of the 12 most common cancers in the CancerLinQ Discovery (CLQD) database

Chasm between cancer quality measures and electronic health record data quality

Quantitating and assessing interoperability between electronic health records

Real-world outcomes in metastatic HR+/HER2-, HER2+ and triple negative breast cancer ...

Retrospective analysis of real-world management of EGFR-mutated advanced NSCLC, ...

Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 and Subsequent ...

Challenges and opportunities to developing a frailty index using electronic health ...

Cancer registry data linkage of electronic health record data from ASCO's ...

Treatment patterns and outcomes associated with sequential and non-sequential use of ...

Survival in the real world: A national analysis of patients treated for early-stage ...

Reaching beyond maximum grade: progress and future directions for modernising the ...

Case studies for overcoming challenges in using big data in cancer

Challenges to using big data in cancer

Evaluation of cost-effectiveness of adjuvant osimertinib in patients with resected ...

Real-world big-data: Strengths and weaknesses of ASCO's CancerLinQ® discovery ...

Health data sharing perspectives of patients receiving care in ...

Multiple myeloma in adolescent and young adults: An ASCO CancerLinQ and SEER analysis

Manuscript - Correspondence

Prognostic impact of second primary malignancies in multiple myeloma: An ASCO ...

Real-world pitfalls of analyzing real-world data: A cautionary note and path forward

Natural history and real-world treatment outcomes for non-small cell lung cancer ...

Augmenting external control arms using Bayesian borrowing: a case study in ...

Real-world patient characteristics and treatment patterns in US patients with ...

Real-world outcomes of different lines and sequences of treatment in BRAF-positive ...

Adverse events and clinical outcomes in patients treated with PD-(L)1 blockade for ...

Clinical and economic impact of recurrence in early-stage non-small-cell lung cancer ...

Real-world treatment patterns and outcomes of patients with metastatic nonsquamous ...

An adjusted treatment comparison comparing amivantamab versus real-world clinical ...

Improving real-world mortality data quality in oncology research: Augmenting ...

Real-world outcomes among patients with metastatic colorectal cancer treated first ...

Real-world clinical outcomes of patients with BRCA-mutated, human epidermal growth ...

Racial differences in patient-reported symptoms and adherence to adjuvant endocrine ...

Unfavorable early-stage Hodgkin lymphoma: assessment of patient characteristics in a ...

Patient profiles, treatment patterns, and outcomes among persistent, recurrent, or ...

Comparison of advanced ovarian cancer patients treated with or without bevacizumab ...

Amivantamab compared with real-world therapies in patients with advanced non-small ...

Outcomes among patients with mantle cell lymphoma post-covalent BTK inhibitor ...

Outcomes for patients with chronic lymphocytic leukemia (CLL) previously treated ...

Treatment patterns and clinical outcomes among patients with relapsed/refractory ...

Utilizing data visualization to identify survival and treatment differences between ...

Real-world use of bevacizumab-awwb, a bevacizumab biosimilar, in US patients with ...

Identification of transgender people with cancer in electronic health records: ...

Impact of broadening trial eligibility criteria for patients with advanced non–small ...

Predicting cardiac adverse events in patients receiving immune checkpoint ...

Real-world treatment patterns and outcomes in PD-L1-positive non-small cell lung ...

The Friends of Cancer Research real world data (RWD) collaboration pilot 2.0: ...

Real-world overall survival using oncology electronic health record data: Friends of ...

Healthcare Resource Utilization and Cost Among Patients Treated for Early-Stage ...

Real-World Treatment Patterns and Effectiveness Outcomes in Patients with ...

Clinical and utilization outcomes associated with tumor mutational burden in a ...

Real-world patterns on tumor mutation burden testing in a pan-tumor population

Treatment effectiveness in a rare oncology indication: Lessons from an external ...

Treatment patterns and overall survival in HER2+ metastatic breast cancer at US ...

Characterization of clinical symptoms by race among women with early stage, hormone ...

Cancer patient perspectives on sharing of medical records and mobile device data for ...

Development of a prognostic factor index among women with HR+/HER2- metastatic ...

Quality of life analysis of patients treated with cetuximab or cisplatin for ...

Real-world effectiveness outcomes in patients diagnosed with metastatic ...

Clinical effectiveness outcomes and healthcare resource utilization of patients ...

Assessing direct costs of treating metastatic triple-negative breast cancer in the ...

Treatment patterns and clinical outcomes with palbociclib-based therapy received in ...

Real-world effectiveness of fulvestrant monotherapy as first endocrine treatment in ...

Treatment patterns, clinical outcomes, health resource utilization, and cost in ...

Real-world outcomes in patients with unresected stage III non-small cell lung cancer

Real-world treatment patterns among patients with unresected stage III non-small ...

Treatment patterns and outcomes in patients with KRAS wild-type metastatic ...

Progression-free survival in patients receiving chemotherapy alone (C) or ...

THRIVE study protocol: a randomized controlled trial evaluating a web-based app and ...

A qualitative exploration of race-based differences in social support needs of ...

Effectiveness outcomes in patients with recurrent or refractory head and neck ...

Treatment patterns and outcomes in stage IV bladder cancer in a community oncology ...

Healthcare costs in patients with advanced non-small cell lung cancer and disease ...

Patient characteristics and costs in recurrent or refractory head and neck cancer: ...

Pretreatment costs of care and time to initial treatment for patients with cancer of ...

unknown primary

Effect of brain metastasis on patient-reported outcomes in advanced NSCLC treated in ...

Treatment outcomes in patients with metastatic neuroendocrine tumors: a ...

Effectiveness outcomes and health related quality of life impact of disease ...

Analysis of the psychological impact of cancer-related symptoms on patients with ...

Maximizing the utility of real-world evidence: integration of structured electronic ...

Burden of symptoms associated with development of metastatic bone disease in ...

Real-world treatment patterns and effectiveness among patients with metastatic ...

Treatment patterns and health resource utilization among patients diagnosed with ...

Clinical trial participants with metastatic renal cell carcinoma differ from ...

Treatment patterns and outcomes among patients with metastatic melanoma treated in ...

Early treatment discontinuation and switching in first-line metastatic breast ...

Use of “Real world” data to describe adverse events for the treatment of metastatic ...

Real-world outcomes in metastatic renal cell carcinoma: insights from a joint ...

Publication

Treatment patterns and clinical effectiveness in metastatic castrate resistant ...

Prostate Cancer

Willingness to pay for preventing chemotherapy induced nausea and vomiting among ...

The association of skin rash severity with overall survival: findings from patients ...

Pancreatic Cancer

Treatment patterns and clinical characteristics of patients with advanced basal cell ...

Basal Cell Carcinoma

Relationship between incidence of fracture and health-related quality-of-life in ...

“Real world” treatment of metastatic renal cell carcinoma in a joint community- ...

Symptom burden & quality of life among patients receiving second-line treatment of ...

Symptom burden and quality of life in patients with follicular lymphoma undergoing ...

Retrospective study of the effect of disease progression on patient reported ...

The Patient Care Monitor-Neutropenia Index: development, reliability, and validity ...

Use of the Patient Care Monitor to screen for depression in adult cancer patients ...

Validation of the Patient Care Monitor (Version 2.0): a review of system assessment ...

A retrospective study of quality of life in a community sample of patients with ...

The relation of trouble sleeping, depressed mood, pain and fatigue in patients with ...

Feasibility and acceptability to patients of a longitudinal system for evaluating ...

Initial treatment and changes in adjuvant endocrine therapy for early stage breast ...

Retrospective chart review of severe infusion reactions with rituximab, cetuximab, ...

Improving health care efficiency and quality using tablet personal computers to ...

Symptom burden for patients with metastatic colorectal cancer treated with ...

Validation of the Cancer Care Monitor items for physical symptoms and treatment side ...

The Cancer Care Monitor: Psychometric content evaluation and pilot testing of a ...

Characteristics, treatment patterns, and outcomes in patients with high-risk locally ...